Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

See our complete portfolio of awards below.

View Funded Institutions
View Funded Investigators
Find Clinical Trials

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Pasadena City College Dr. Pamela Eversole-Cire Umbrella for CIRM Bridges and COMPASS: Grant Application Bridges to Stem Cell Research and Regenerative Medicine $4,588,500
Cal State Univ, Sacramento Kimberly A Mulligan Umbrella for CIRM Bridges and COMPASS: Grant Application Developing a Skilled and Diverse Master’s-Level Workforce in Regenerative Medicine $3,868,800
Cal State Univ, San Bernadino Daniel Nickerson Umbrella for CIRM Bridges and COMPASS: Grant Application From Pluripotent Students to Stem Cell Scholars $6,918,000
SJSU Research Foundation Bree Grillo – Hill Umbrella for CIRM Bridges and COMPASS: Grant Application Building the Regenerative Medicine Workforce through Stem Cell Internships in Laboratory-based Learning (SCILL) $5,857,000
University of California, San Francisco Dr. Julie B Sneddon Funding Opportunity Discovery Research Decoding Human Pancreatic Progenitor Biology to Enable Next-Generation Stem Cell-based Therapies for Type 1 Diabetes $2,499,875
University of California, San Diego Shiri Gur-Cohen Funding Opportunity Discovery Research Phoenix WNTears: A Platform for Selectivity Expanding Adult Stem Cell Potency and Plasticity $2,500,000
University of Southern California Leonardo Morsut Funding Opportunity Discovery Research Engineering Nephron Connectivity in Human Kidney Tissue Using Synthetic Signaling Centers $2,500,000
University of California, San Diego Sven Heinz Funding Opportunity Discovery Research Decoding regulatory sequence function during human brain organoid development $2,500,000
Salk Institute for Biological Studies Dr. Samuel L Pfaff Funding Opportunity Discovery Research Characterizing how neurons from human stem cell transplants integrate into spinal neural circuits following injury $2,499,999
University of Southern California Dr. Justin K Ichida Funding Opportunity Discovery Research Leveraging iPSCs and a deep learning-based virtual cell model to identify therapeutic targets for ALS $2,500,000
University of California, San Francisco Audrey Parent Funding Opportunity Discovery Research Advancing next-generation models for the development of thymoregenerative medicines $2,500,000
California Institute of Technology Magdalena Zernicka-Goetz Funding Opportunity Discovery Research Spatiotemporal Control of Human Primordial Germ Cell Fate by the Embryonic Niche $2,425,796
Gladstone Institutes, J. David Christina Theodoris Funding Opportunity Discovery Research Temporal AI models for programming therapeutic cell state transitions $2,499,998
University of California, San Francisco Dr Diana Jean Laird Funding Opportunity Discovery Research Neurovascular control of follicle growth using stem-cell derived ovary assembloids $2,499,997
University of California, Berkeley Dr. Andreas Stahl Funding Opportunity Discovery Research Generating biological age in a stem cell-based complex disease model of osteoarthritis $2,499,999
The Regents of the University of California on behalf of its Riverside Campus Joshua Morgan Funding Opportunity Discovery Research Validating Safety and Efficacy of Extremeophile Stress Tolerance Transgenes in Stem Cells $2,499,999
University of Southern California Mohamed Abou-el-Enein Funding Opportunity Discovery Research Revealing the Mechanistic Architecture Governing CAR-T Cell Potency and Failure at Single-Cell Resolution $2,499,738
University of California, Los Angeles Kitai Kim Funding Opportunity Discovery Research Foundational Mapping of Splicing-Derived Neoantigen Recognition in Human Sarcoma Using Stem Cell-Enabled Immune Platforms $2,500,000
University of California, San Francisco Dr. Neel S Singhal M.D. Funding Opportunity Discovery Research Uncovering disease and cell-type-specific constraints on therapeutic delivery using a human CNS tissue discovery platform $2,500,000
University of California, Los Angeles Dr. Aya Barzelay Wollman Funding Opportunity Discovery Research Mapping Human Retinal Niches to Improve Stem-Cell Therapy for Geographic Atrophy $2,500,000
University of California, San Francisco James Bayrer Funding Opportunity Discovery Research Impact of Sex-Differences on Intestinal Stem Cell Function in Pediatric Inflammatory Bowel Disease $2,499,999
University of Southern California Dr. Lu Wang Funding Opportunity Discovery Research A precision organoid platform to investigate APOE4 dependent cerebrovascular impairments $2,500,000
University of California, San Francisco Tomasz Nowakowski Funding Opportunity Discovery Research Leveraging lessons from normal development to overcome barriers to efficient transplantation of stem cell derived cortical neurons. $2,500,000
University of California, San Diego Professor Alysson R Muotri Funding Opportunity Discovery Research Allelic Expression States as Determinants of Neurodevelopmental Disorder Risk $2,500,000
University of California, San Francisco Yin Shen PhD Funding Opportunity Discovery Research Systematic cell-type-resolved single-base resolution functional characterization of neurodevelopmental risk genes $2,500,000
University of California, San Francisco Katja Gabriele Weinacht Preclinical Stage Projects Therapeutic Restoration of Immune Function through iPSC-derived Human Thymic Epithelial Cells $12,999,871
Stanford University Dr. Katja Weinacht Preclinical Stage Projects Therapeutic Restoration of Immune Function through iPSC-derived Human Thymic Epithelial Cells $0
EVADE Therapeutics Sonja Schrepfer Preclinical Stage Projects Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes $12,480,000
University of Southern California Charles Murry Preclinical Stage Projects Regenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes. $6,891,118
University of California, Los Angeles Dr. Lili Yang Preclinical Stage Projects Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis $6,755,735
Scribe Therapeutics Brett Staahl Preclinical Stage Projects A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events $12,714,480
4D Molecular Therapeutics, Inc. Sara Collins Preclinical Stage Projects Gene Therapy for Alpha-1 Anti-Trypsin Deficiency $5,915,073
AcuraStem Incorporated Mr. Samuel V. Alworth MS, MBA Preclinical Stage Projects Late-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies $7,500,000
Cure Rare Disease Dr. Tahseen Mozaffar Preclinical Stage Projects Advancement of a myotropic, liver-detargeting therapy for LGMD2i/R9 $7,292,297
Scribe Therapeutics Brett Staahl Preclinical Stage Projects A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia $13,000,000
Savanna Biotherapeutics, Inc. Dr. Sunil Gandhi Ph.D Preclinical Stage Projects Microglia replacement therapy for CSF1R-related Leukoencephalopathy $12,993,456
Cedars-Sinai Medical Center Dr. David Joseph Lefer Preclinical Stage Projects TY1 and Semaglutide to Treat Cardiometabolic HFpEF $10,571,220
University of California, San Diego Dr. Stephanie Cherqui Preclinical Stage Projects CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia $7,423,504
Cedars-Sinai Medical Center Dr. Alessandra Ciullo Preclinical Stage Projects Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy $10,419,929
Navega Therapeutics Ana Maria Moreno Preclinical Stage Projects Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders $9,486,864
Scripps Health Dr. Darryl D. D’Lima Preclinical Stage Projects Stem Cell-Based Cartilage Tissue Regeneration $12,715,000
Stanford University Dr. Bertha Chen Preclinical Stage Projects Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence $7,275,596
Loma Linda University Hisham Abdel-Azim CCCE Grant Inland Empire and Desert Region CIRM Community Care Center of Excellence $9,000,000
Fresno Community Hospital and Medical Center Haifaa Abdulhaq CCCE Grant Establishing a CIRM Community Care Center of Excellence in the Central Valley $8,996,101
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center Lynda Polgreen MD CCCE Grant South Los Angeles Community Center of Excellence for Regenerative Medicine $9,000,000
Stanford University Dr. Michael P Snyder PhD ReMIND – Discovery Stage ReMIND Dissecting cell-specific genetic and molecular drivers of amyotrophic lateral sclerosis for therapeutic insights $12,999,837
Stanford University Sergiu P Pasca ReMIND – Discovery Stage ReMIND Transplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders $13,999,999
University of California, Los Angeles Daniel Geschwind ReMIND – Discovery Stage ReMIND Advancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders $13,957,175
University of California, San Diego Dr. Gene Wei-Ming Yeo ReMIND – Discovery Stage ReMIND Reversing age-dependent neurodegeneration by elimination of RNA pollution $11,946,234
Salk Institute for Biological Studies Christian Metallo ReMIND – Discovery Stage ReMIND Tracing the metabolic basis of neurological disorders $12,995,613
1 … 20 21 22 23 24 25 26 27 28 29 30 31 32 33